Addition of purine bases to the growth medium of Escherichia coli and Salmonella typhimurium stops purine de novo synthesis. The structural genes encoding the 13 enzymes of the purine de novo synthesis pathway are organized in nine genetically unlinked transcriptional units. Expression of these genes is negatively regulated by purines (13) . A number of mutants defective in this repression have previously been isolated in both E. coli (7) and S. typhimurium (2, 16) . Several of these mutants were found to be resistant to the toxic hypoxanthine analog 6-mercaptopurine (2, 7); none was characterized genetically.
Cytosine deaminase encoded by codA is a pyrimidine salvage enzyme. It catalyzes the deamination of cytosine to uracil and enables the cell to utilize cytosine for pyrimidine nucleotide synthesis. The regulation of cytosine deaminase synthesis is very complex. Synthesis is derepressed under pyrimidine and nitrogen limitation and is repressed by exogenous purines (13) . In this report, we describe the properties of a purR::TnJO mutant which was obtained as a mutant defective in purine repression of cytosine deaminase synthesis. The mutation also affects the regulation of purF and purD expression and confers resistance to 6-mercaptopurine. Media and gro*th conditions. The growth medium was AB medium (4) containing glucose (0.2%) and thiamine (1 ,ug/ ml); solid medium also contained 1.5% agar. Unless otherwise stated, supplements were added at the following final concentrations: hypoxanthine, 30 p,g/ml; 2-amino-4-hydroxypyrimidine (isocytosine), 10 ,ug/ml; 5-fluorocytosine, 20 ,ug/ml; 6-mercaptopurine, 150 ,ug/ml; Casamino Acids, 0.2%; ampicillin, 50 ,ug/ml; tetracycline, 10 jig/ml; and pyridoxal * Corresponding author.
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hydrochloride, 1 Fg/ml. Luria broth (11) activities are given in units; 1 U is the amount of enzyme that produces 1 nmol of product per min at 37°C. Hypoxanthine utilization was determined in exponentially growing cells at a density of 5 x 108 cells per ml. Cells were washed and suspended in fresh AB glucose medium containing 6 ,uM [14C]hypoxanthine (1 Ci/mol). Portions were removed after 1 and 2 min, precipitated in 5% trichloroacetic acid, and filtered on glass filters. The filters were washed, dried, and counted. Protein determinations were performed as described by Lowry et al. (9) .
Genetic techniques. TnJO mutagenesis was performed as described by Kleckner et al. (5) with lambda NK370. Infection of S0106 with 2 x 1011 PFU of the bacteriophage at a mnultiplicity of infection of about 1 resulted in 12,000 tetracycline-resistant colonies. Selection for purR: :TnJO mutants was done by replication to glucose minimal plates containing Casamino Acids, isocytosine, hypoxanthine, and tetracycline. P1-mediated generalized transduction was performed as described by Miller (11) . Supplements for aroD mutants were tryptophane (20 ,ug/ml), phenylalanine (20 ,ug/ml), tyrosine (20 ,ug/ml), p-aminobenzoic acid (1 p.g/ml), p-hydroxybenzoic acid (0.05 p.g/ml), and 3,4-dihydroxybenzoic acid (0.5 ,ug/ml).
DNA techniques. The methods for plasmid isolation, restriction endonuclease digestion and ligation of DNA fragments, and transformation of plasmid DNA have been described by Maniatis et al. (10) .
RESULTS AND DISCUSSION
Selection and characterization of purR6: :TnlO. Pyrimidinerequiring mutants of E. coli can utilize cytosine as the sole pyrimidine source provided that they contain a functional cytosine deaminase (13) . The cytosine analog isocytosine, which is a poor substrate of cytosine deaminase, is deaminated to uracil and may serve as a pyrimidine source in cells containing derepressed levels of cytosine deaminase. Thus, a pyrimidine-requiring mutant grows well on isocytosine in glucose minimal medium, whereas it cannot grow on isocytosine if the medium is supplemented with hypoxanthine because of the repressing effect of this compound on cytosine deaminase synthesis.
The pyrimidine-requiring strain S0106 was mutagenized with TnlO (see Materials and Methods), and tetracyclineresistant mutants capable of growth on isocytosine in the presence of hypoxanthine were selected. Among the transposition events, 14 resulted in mutants with the desired phenotype. On further characterization, one of these (S05046) was found to be resistant to 6-mercaptopurine. A P1 lysate prepared on S05046 was used to transduce S0106 to tetracycline resistance. Of 200 transductants, all grew on isocytosine plus hypoxanthine and were 6-mercaptopurine resistant, indicating that these phenotypes were caused by the TnWO insertion.
The purR6::TnJO mutation resulted in derepressed levels of cytosine deaminase under purine-repressing conditions ( Table 2) . The resistance to 6-mercaptopurine suggested that the mutation also affects regulation of purine nucleotide synthesis. To confirm this, the levels of two enzymes of the purine de novo synthetic pathway, PRPP amidotransferase and GAR synthetase, were determined. The genes encoding these two enzymes, purF and purD, belong to two different transcriptional units. The purR6::TnJO mutation rendered synthesis of both enzymes virtually insensitive to purine repression ( Table 2) .
The lack of purine repression observed in the purR6: :TnJO mutant may be due to inactivation of a regulatory protein (i.e., a repressor) or may be the result of inactivation of an enzyme involved in hypoxanthine utilization. Hypoxanthine utilization, measured as hypoxanthine incorporated into acid-insoluble material, was determined for both wild-type and mutant cells. Hypoxanthine utilization was the same in both strains ( Table 2 ), suggesting that the purR gene encodes a repressor protein. (Table 3 and Fig. 1 ).
S. typhimurium mutants defectiye in transcriptional regulation of the purine biosynthesis pathway have recently been isolated. The mutations affect a single locus, purK, which was mapped near 30 min on the S. typhimurium chromosome (Guo-Min, Abstr. Annu. Meet. Am. Soc. Microbiol. 1988). The genetic data suggest that the purK locus in S. typhimurium is homologous to the purR locus in E. coli.
Molecular cloning of the wild-type purR gene. 5-Fluorocytosine is toxic to pyrimidine-prototrophic strains of E. coli because of its conversion to 5-fluorouracil catalyzed by cytosine deaminase (13) . Exogenous hypoxanthine reverses this toxicity because it represses the synthesis of cytosine deaminase. Pyrimidine-prototrophic strains carrying th, purR6: :TnJO mutation contain constitutive levels of cytosine deaminase and are sensitive to 5-fluorocytosine in the presence of hypoxanthine. Thus, provided that the purR gene encodes a trans-acting, dominant element required for purine repression of cytosine deaminase synthesis, a plasmid carrying the purR gene will confer resistance to 5-fluorocytosine in the presence of hypoxanthine when introduced into a purR6::TnJO strain.
A mixture of E. coli chromosomal DNA and pBR322 (3) was digested with EcoRI, ligated, aqll transformed into S05066. Transformants were selected on glucose minimal plates containing 5-fluorocytosine, hypoxanthine, and ampicillin. Plasmid DNA from two of the transformants yielded 5-fluorocytosine-resistant colonies upon retransformation of S05066. Both plasmids (pMK150 and pMK151) contained a 9.5-kilobase EcoRI fr;4gment inserted in the EcoRI site of pBR322. pMK150 complemented the purR6: :TnJO mutation by restoring purine repression of synthesis of cytosine deaminase, PRPP amidotransferase, and GAR synthetase ( Table   TABLE 4 4). Thus, purl encodes a trans-acting regulatory element, probably a repressor, involved in the control of both cytosine utilization and purine nucleotide synthesis in E. coli.
A restriction map of the 9.5-kilobase EcoRI insert in pMK150 is shown in Fig. 2 . It confirms the chromosomal location of the purR gene as determined genetically, since the same restriction pattern is found around kilobase 1760 on the E. coli restriction map between the uidR gene (35.9 min) and the Ipp gene (36.3 min) (6) .
